創薬インフォマティクス市場：ソリューション、機能、エンドユーザー、用途別-2025-2030年の世界予測

創薬インフォマティクス市場の2023年の市場規模は29億米ドルで、2024年には31億9,000万米ドルに達すると予測され、CAGR 9.92％で成長し、2030年には56億4,000万米ドルに達すると予測されています。

創薬インフォマティクスには、創薬プロセスを改善するための計算、統計、情報技術の応用が含まれます。その必要性は、生物学的に活性な化合物をターゲットとする膨大な複雑性とともに、コスト効率と創薬プロセスの加速に対する需要の高まりから生じています。その応用範囲は、創薬ターゲットの同定、リード化合物の探索、アッセイ開発、バーチャルスクリーニングに及ぶ。最終用途の範囲としては、製薬会社、バイオテクノロジー企業、受託研究機関、学術機関などが挙げられます。

市場成長は、創薬プロセスの予測精度を高めるビッグデータ分析、AI、機械学習の進歩に大きく影響されています。個別化医療の急増とクラウドベースのソリューション採用の増加が、この成長をさらに後押ししています。精密医療のためのAIとインフォマティクスの統合、分子データ共有のための共同プロジェクト、新興市場への進出などにビジネスチャンスがあります。こうした機会がある一方で、課題としてはインフォマティクス・ツールの高コストやデータ管理の複雑さが挙げられます。また、厳しい規制やデータプライバシーに関する懸念も、市場拡大のハードルとなっています。

データ可視化のための直感的なユーザー・インターフェースの開発、プラットフォーム間のデータ統合の合理化、より優れた予測モデルのためのアルゴリズムの堅牢性の強化などの分野でイノベーションが促進される可能性があります。企業は、創薬で生成されるデータ量の増大に継続的に適応できるスケーラブルなソリューションの構築に注力すべきです。また、学術機関や業界関係者と協力することで、知識やリソースを共有し、イノベーションを促進することができます。

市場はダイナミックで競争が激しく、多くのプレーヤーが急速な進化に貢献しています。企業は、技術動向の最先端を維持し、学際的研究を促進し、特定の治療分野に特化したインフォマティクス・ソリューションで競争優位に立つことを優先すべきです。戦略的投資と革新的コラボレーションの組み合わせにより、企業は複雑な創薬インフォマティクスを効果的にナビゲートし、市場の拡大と成功を促進することができます。

市場力学：急速に進化する創薬インフォマティクス市場の主要市場インサイトを公開

創薬インフォマティクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 希少・希少疾病管理における精密医療ニーズの高まり
  • 創薬手順に対する政府の好意的支援
  • 創薬・薬剤開発におけるバイオインフォマティクスソフトウェアの利用増加
• 市場抑制要因
  • バイオインフォマティクスのインフラ整備に莫大なコストがかかること
• 市場機会
  • 創薬インフォマティクス開発のための潜在的研究投資
  • 創薬手順における次世代技術の統合
• 市場の課題
  • 熟練した経験豊富な専門家の不足

ポーターのファイブフォース：創薬インフォマティクス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：創薬インフォマティクス市場における外部からの影響の把握

外部マクロ環境要因は、創薬インフォマティクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析創薬インフォマティクス市場における競合情勢の把握

創薬インフォマティクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス創薬インフォマティクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、創薬インフォマティクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨創薬インフォマティクス市場における成功への道筋を描く

創薬インフォマティクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 希少疾患および難病の管理における精密医療の必要性の高まり
    • 医薬品の発見手順に対する政府の好意的な支援
    • 医薬品の発見と開発におけるバイオインフォマティクスソフトウェアの利用増加
  • 抑制要因
    • バイオインフォマティクス基盤の開発には莫大なコストがかかる
  • 機会
    • 創薬インフォマティクスの開発のための潜在的な調査投資
    • 創薬プロセスにおける次世代技術の統合
  • 課題
    • 熟練した経験豊富な専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 創薬インフォマティクス市場：ソリューション別

• サービス
• ソフトウェア

第7章 創薬インフォマティクス市場機能別

• ドッキング
• ライブラリとデータベースの準備
• 分子モデリング
• シーケンスとターゲットデータ分析

第8章 創薬インフォマティクス市場：エンドユーザー別

• 契約調査機関（CRO）
• 製薬・バイオテクノロジー企業

第9章 創薬インフォマティクス市場：用途別

• 医薬品開発
  • 臨床試験
  • 前臨床試験
• 創薬

第10章 南北アメリカの創薬インフォマティクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の創薬インフォマティクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの創薬インフォマティクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Accenture PLC
• Agilent Technologies, Inc.
• Aragen Life Sciences Ltd.
• Boehringer Ingelheim International GmbH
• Cadence Design Systems, Inc.
• Certara, Inc.
• Charles River Laboratories International, Inc.
• ChemAxon Ltd.
• Cognizant Technology Solutions Corporation
• Collaborative Drug Discovery, Inc
• Crown Bioscience, Inc.
• Dassault Systemes SE
• Eurofins DiscoverX Products LLC
• Evotec AG
• Illumina, Inc.
• Infosys Limited
• InSilico Medicine
• International Business Machines Corporation
• Jubilant Biosys Ltd.
• Oracle Corporation
• PerkinElmer Inc.
• Schrodinger, Inc.
• Selvita S.A.
• Thermo Fisher Scientific Inc.
• WuXi AppTec Co., Ltd.

LIST OF FIGURES

• FIGURE 1. DRUG DISCOVERY INFORMATICS MARKET RESEARCH PROCESS
• FIGURE 2. DRUG DISCOVERY INFORMATICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. DRUG DISCOVERY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. DRUG DISCOVERY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG DISCOVERY INFORMATICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRUG DISCOVERY INFORMATICS MARKET DYNAMICS
• TABLE 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DOCKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY LIBRARIES & DATABASE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SEQUENCING & TARGET DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CRO), BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 40. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 41. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 42. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 67. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 68. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 69. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 72. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 73. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 74. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 112. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 138. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 143. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 148. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 153. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 158. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 159. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 160. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 163. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 168. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 173. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 178. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 179. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 180. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 183. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 184. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 185. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 188. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 203. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 208. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 213. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 218. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 233. DRUG DISCOVERY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 234. DRUG DISCOVERY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2023

The Drug Discovery Informatics Market was valued at USD 2.90 billion in 2023, expected to reach USD 3.19 billion in 2024, and is projected to grow at a CAGR of 9.92%, to USD 5.64 billion by 2030.

Drug Discovery Informatics involves applying computational, statistical, and informational techniques to improve the drug discovery process. The necessity arises from the increasing demand for cost-efficient and accelerated drug development processes, as well as the vast complexity involved in targeting biologically active compounds. Its applications span drug target identification, lead discovery, assay development, and virtual screening. In terms of end-use scope, it finds a place in pharmaceutical companies, biotechnology firms, contract research organizations, and academic institutions.

Market growth is significantly influenced by advancements in big data analytics, AI, and machine learning, which enhance predictive accuracy in drug discovery processes. The surge in personalized medicine and rising adoption of cloud-based solutions contribute further to this growth. Opportunities lie in the integration of AI with informatics for precision medicine, collaborative projects to share molecular data, and expanding into emerging markets. Despite these opportunities, challenges include high costs of informatics tools and data management complexities. Rigorous regulations and data privacy concerns also pose hurdles to market expansion.

Innovation can thrive in areas such as developing intuitive user interfaces for data visualization, streamlining data integration across platforms, and enhancing algorithm robustness for better predictive models. Companies should focus on creating scalable solutions that can continuously adapt to the increasing data volume generated in drug discovery. Collaborating with academic institutes and industry players can also facilitate innovation through shared knowledge and resources.

The market is dynamic and competitive, with numerous players contributing to its rapid evolution. Businesses should prioritize staying at the cutting edge of technology trends, fostering interdisciplinary research, and tailoring informatics solutions to specific therapeutic areas to gain a competitive edge. Through a combination of strategic investments and innovative collaborations, companies can effectively navigate the complexities of drug discovery informatics to foster expansion and market success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Discovery Informatics Market

The Drug Discovery Informatics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing need for precision medicine in rare and orphan disease management
  • Favorable government support for drug discovery procedures
  • Rising use of bioinformatic software for drug discovery and development
• Market Restraints
  • Involvement of huge cost for development of bio-informatic infrastructure
• Market Opportunities
  • Potential research investments for the development of drug discovery informatics
  • Integration of next-generation technologies in drug discovery procedures
• Market Challenges
  • Lack of skilled and experienced professionals

Porter's Five Forces: A Strategic Tool for Navigating the Drug Discovery Informatics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Discovery Informatics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Discovery Informatics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Discovery Informatics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Discovery Informatics Market

A detailed market share analysis in the Drug Discovery Informatics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Discovery Informatics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Discovery Informatics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Discovery Informatics Market

A strategic analysis of the Drug Discovery Informatics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Informatics Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Agilent Technologies, Inc., Aragen Life Sciences Ltd., Boehringer Ingelheim International GmbH, Cadence Design Systems, Inc., Certara, Inc., Charles River Laboratories International, Inc., ChemAxon Ltd., Cognizant Technology Solutions Corporation, Collaborative Drug Discovery, Inc, Crown Bioscience, Inc., Dassault Systemes SE, Eurofins DiscoverX Products LLC, Evotec AG, Illumina, Inc., Infosys Limited, InSilico Medicine, International Business Machines Corporation, Jubilant Biosys Ltd., Oracle Corporation, PerkinElmer Inc., Schrodinger, Inc., Selvita S.A., Thermo Fisher Scientific Inc., and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Informatics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Solutions, market is studied across Services and Software.
• Based on Functions, market is studied across Docking, Libraries & Database Preparation, Molecular Modeling, and Sequencing & Target Data Analysis.
• Based on End-User, market is studied across Contract Research Organizations (CRO) and Pharmaceutical & Biotechnology Companies.
• Based on Application, market is studied across Drug Development and Drug Discovery. The Drug Development is further studied across Clinical Trials and Preclinical Testing.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing need for precision medicine in rare and orphan disease management
    • 5.1.1.2. Favorable government support for drug discovery procedures
    • 5.1.1.3. Rising use of bioinformatic software for drug discovery and development
  • 5.1.2. Restraints
    • 5.1.2.1. Involvement of huge cost for development of bio-informatic infrastructure
  • 5.1.3. Opportunities
    • 5.1.3.1. Potential research investments for the development of drug discovery informatics
    • 5.1.3.2. Integration of next-generation technologies in drug discovery procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled and experienced professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Discovery Informatics Market, by Solutions

• 6.1. Introduction
• 6.2. Services
• 6.3. Software

7. Drug Discovery Informatics Market, by Functions

• 7.1. Introduction
• 7.2. Docking
• 7.3. Libraries & Database Preparation
• 7.4. Molecular Modeling
• 7.5. Sequencing & Target Data Analysis

8. Drug Discovery Informatics Market, by End-User

• 8.1. Introduction
• 8.2. Contract Research Organizations (CRO)
• 8.3. Pharmaceutical & Biotechnology Companies

9. Drug Discovery Informatics Market, by Application

• 9.1. Introduction
• 9.2. Drug Development
  • 9.2.1. Clinical Trials
  • 9.2.2. Preclinical Testing
• 9.3. Drug Discovery

10. Americas Drug Discovery Informatics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Drug Discovery Informatics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Drug Discovery Informatics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Accenture PLC
• 2. Agilent Technologies, Inc.
• 3. Aragen Life Sciences Ltd.
• 4. Boehringer Ingelheim International GmbH
• 5. Cadence Design Systems, Inc.
• 6. Certara, Inc.
• 7. Charles River Laboratories International, Inc.
• 8. ChemAxon Ltd.
• 9. Cognizant Technology Solutions Corporation
• 10. Collaborative Drug Discovery, Inc
• 11. Crown Bioscience, Inc.
• 12. Dassault Systemes SE
• 13. Eurofins DiscoverX Products LLC
• 14. Evotec AG
• 15. Illumina, Inc.
• 16. Infosys Limited
• 17. InSilico Medicine
• 18. International Business Machines Corporation
• 19. Jubilant Biosys Ltd.
• 20. Oracle Corporation
• 21. PerkinElmer Inc.
• 22. Schrodinger, Inc.
• 23. Selvita S.A.
• 24. Thermo Fisher Scientific Inc.
• 25. WuXi AppTec Co., Ltd.